Israel Englander Novo Nordisk A S Put Options Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $22.8 Million - $27.8 Million	191,400 Added 96.13%	390,500 $46.5 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $24.4 Million - $29.2 Million	199,100 New	199,100 $28.4 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $877,800 - $1.05 Million	-10,000 Reduced 50.0%	10,000 $1.03 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $1.98 Million - $2.19 Million	12,700 Added 173.97%	20,000 $3.24 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $966,082 - $1.16 Million	7,300 New	7,300 $1.16 Million

1,952

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $238B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.